USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/10999
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTurcan, Valeria-
dc.date.accessioned2020-07-06T11:11:05Z-
dc.date.available2020-07-06T11:11:05Z-
dc.date.issued2018-
dc.identifier.citationValeria TURCAN. Evaluation of the thromboembolic risk in patients with atrial fibrillation. In: MedEspera: the 7th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2018, p. 48-49.en_US
dc.identifier.urihttps://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/10999-
dc.descriptionNicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldovaen_US
dc.description.abstractIntroduction. Atrial fibrillation (AF) is considered to be a new 21st-century epidemic, which by the end of 2060 shall affect an estimated 18 million people. More than 6 million Europeans suffer from AF, while in the United States AF is the cause of hospitalization of more than one third of the patients with heart rhythm disorders.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectatrial fibrillationen_US
dc.subjectstrokeen_US
dc.subjectthromboembolismen_US
dc.titleEvaluation of the thromboembolic risk in patients with atrial fibrillationen_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2018

Files in This Item:
File Description SizeFormat 
Turcan_V_Evaluation_p._48_49.pdf523.52 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback